House of Lords Official Report

House of Lords Official Report

Vol. 754 Monday No. 16 30 June 2014 PARLIAMENTARY DEBATES (HANSARD) HOUSE OF LORDS OFFICIAL REPORT ORDER OF BUSINESS Questions Health: Multiple Sclerosis................................................................................................................................................1527 Busking ...............................................................................................................................................................................1529 Education: Citizenship Studies ........................................................................................................................................1531 Disabled Students’ Allowance..........................................................................................................................................1535 Co-operative and Community Benefit Societies and Credit Unions Act 2010 (Consequential Amendments) Regulations 2014 Motion to Approve ...........................................................................................................................................................1537 Legislative Reform (Clinical Commissioning Groups) Order 2014 Motion to Approve ...........................................................................................................................................................1537 Criminal Justice and Courts Bill Second Reading..................................................................................................................................................................1537 EU Council June 2014 Statement ............................................................................................................................................................................1572 Criminal Justice and Courts Bill Second Reading (Continued) ...........................................................................................................................................1583 Grand Committee Financial Services and Markets Act 2000 (Regulated Activities) (Green Deal) (Amendment) Order 2014 Motion to Consider....................................................................................................................................................GC 191 Banking Act 2009 (Banking Group Companies) Order 2014 Motion to Consider....................................................................................................................................................GC 194 Banking Act 2009 (Exclusion of Investment Firms of a Specified Description) Order 2014 Banking Act 2009 (Restriction of Partial Property Transfers) (Recognised Central Counterparties) Order 2014 Motions to Consider ..................................................................................................................................................GC 202 Banking Act 2009 (Third Party Compensation Arrangements for Partial Property Transfers) (Amendment) Regulations 2014 Anonymous Registration (Northern Ireland) (No. 2) Order 2014 Motions to Consider ..................................................................................................................................................GC 203 Donations to Candidates (Anonymous Registration) Regulations 2014 European Parliamentary Elections (Anonymous Registration) (Northern Ireland) Regulations 2014 Motions to Consider ..................................................................................................................................................GC 207 Northern Ireland Assembly (Elections) (Amendment) Order 2014 Representation of the People (Northern Ireland) (Amendment) Regulations 2014 Health Care and Associated Professions (Indemnity Arrangements) Order 2014 Motions to Consider ..................................................................................................................................................GC 208 United Nations International Widow’s Day Question for Short Debate........................................................................................................................................GC 216 Written Statements.............................................................................................................................................WS 143 Written Answers ..................................................................................................................................................WA 205 £4·00 Lords wishing to be supplied with these Daily Reports should give notice to this effect to the Printed Paper Office. No proofs of Daily Reports are provided. Corrections for the bound volume which Lords wish to suggest to the report of their speeches should be clearly indicated in a copy of the Daily Report, which, with the column numbers concerned shown on the front cover, should be sent to the Editor of Debates, House of Lords, within 14 days of the date of the Daily Report. This issue of the Official Report is also available on the Internet at www.publications.parliament.uk/pa/ld201415/ldhansrd/index/140630.html PRICES AND SUBSCRIPTION RATES DAILY PARTS Single copies: Commons, £5; Lords £4 Annual subscriptions: Commons, £865; Lords £600 LORDS VOLUME INDEX obtainable on standing order only. Details available on request. BOUND VOLUMES OF DEBATES are issued periodically during the session. Single copies: Commons, £105; Lords, £60 (£100 for a two-volume edition). Standing orders will be accepted. THE INDEX to each Bound Volume of House of Commons Debates is published separately at £9·00 and can be supplied to standing order. All prices are inclusive of postage. The first time a Member speaks to a new piece of parliamentary business, the following abbreviations are used to show their party affiliation: Abbreviation Party/Group CB Cross Bench Con Conservative Con Ind Conservative Independent DUP Democratic Unionist Party GP Green Party Ind Lab Independent Labour Ind LD Independent Liberal Democrat Ind SD Independent Social Democrat Lab Labour Lab Ind Labour Independent LD Liberal Democrat LD Ind Liberal Democrat Independent Non-afl Non-affiliated PC Plaid Cymru UKIP UK Independence Party UUP Ulster Unionist Party No party affiliation is given for Members serving the House in a formal capacity, the Lords spiritual, Members on leave of absence or Members who are otherwise disqualified from sitting in the House. © Parliamentary Copyright House of Lords 2014, this publication may be reproduced under the terms of the Open Parliament licence, which is published at www.parliament.uk/site-information/copyright/. 1527 Health: Multiple Sclerosis[30 JUNE 2014] Health: Multiple Sclerosis 1528 past two or three months, which is great news. Is there House of Lords any chance that these new drugs will be included in the risk-sharing initiative with industry? Monday, 30 June 2014. Earl Howe: My Lords, I think that the answer is 2.30 pm almost certainly no because the risk-sharing scheme initiated under the previous Government is quite complex Prayers—read by the Lord Bishop of Oxford. to administer and we would need to be persuaded that the administrative burdens associated with it were worth while. Now that we have the NICE process, it is Health: Multiple Sclerosis probably best that NICE should look at these drugs in Question the context of its new clinical guideline, which is what the stakeholder groups thought was preferable. 2.36 pm Lord Blencathra (Con): My Lords, I declare a personal, Asked by Baroness Gardner of Parkes though not a financial, interest in this Question. My To ask Her Majesty’s Government what plans noble friend may be aware that there is a drug called they have to introduce new treatment for relapsing- benztropine which has been approved for the past remitting multiple sclerosis. 10 years for use in Parkinson’s patients. We know that it is not carcinogenic, mutagenic, teratogenic or any other genic—it is safe. US researchers have just discovered The Parliamentary Under-Secretary of State, Department that it seems to completely restore the myelin sheath of Health (Earl Howe) (Con): My Lords, it is important on the spinal cord, at least in laboratory animals. This that people are able to access the innovative and effective is of enormous interest to MS patients. Will my noble new treatments they need. Many thousands of people friend add benztropine to the list of medicines for in England with multiple sclerosis have benefited from urgent consideration by his early access to medicines the medicines recommended by the National Institute scheme? for Health and Care Excellence or covered by the MS risk-sharing scheme. Earl Howe: My Lords, we are keen to see candidates being proposed for the early access to medicines scheme. Baroness Gardner of Parkes (Con): My Lords, I If a body of evidence suggests that benztropine could thank the Minister for that reply. People with multiple qualify for designation as a promising innovative sclerosis consider that specialist MS nurses are the key medicine—a PIM—the Medicines and Healthcare health professionals for providing responsive, person- products Regulatory Agency stands ready to consider centred, co-ordinated and integrated care. The latest such evidence. However, it is for the manufacturer of MS Trust report assesses the provision of MS nurses the drug, not the Government, to decide whether it across the UK and considers that there is a shortage of wishes to propose the drug as a candidate for the around 200, and that more specialist nurses are required scheme. to ensure

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    99 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us